Dorzopt 20 mg Eye Drops
PDF Leaflet Revision Date: 13 June 2023
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of elevated intraocular pressure in glaucoma and ocular hypertension.
Dosage (summary)
1 drop in affected eye(s) 3 times daily as monotherapy; 2 times daily with beta-blockers.
Special Populations
- Hepatic impairment
- Renal impairment
Pregnancy & Breastfeeding
Not recommended in pregnancy; safety during breastfeeding not established.
Key Drug Interactions
- Timolol
- Betaxolol
- Oral carbonic anhydrase inhibitors
Contraindications
- Hypersensitivity to dorzolamide
- Moderate to severe renal impairment
- Contact lens use
Common side effects
- Headache
- Dizziness
- Burning and stinging
- Conjunctivitis
Counselling Points
- Remove contact lenses before use
- Monitor for allergic reactions
- Use with caution in dry eye patients
Serious warnings
- Risk of severe allergic reactions
- Caution in patients with renal calculi
Important Disclaimer
The Dorzopt 20 mg Eye Drops professional information leaflet below is the property of Austell Pharmaceuticals and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
